Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(9):750-753; doi:10.1093/jnci/91.9.750
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Reynolds, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reynolds, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 9, 750-753, May 5, 1999
© 1999 Oxford University Press

NEWS

Declining Breast Cancer Mortality: What's Behind It?

Tom Reynolds

The British public health community was thrown into a tumult last month by widespread media reports that a new Swedish study raised serious doubt about the effectiveness of mammography screening.

"Breast Screening `Doesn't Prevent Deaths' " announced a front page headline March 11 in the London tabloid Daily Mail, and other media outlets joined the chorus, though less sensationally.

In fact, the study was roundly and internationally criticized for severe design flaws, and United Kingdom and Swedish officials rushed to reassure women that mammograms can save lives. But the debate over the value of screening points to a crucial question in cancer epidemiology: Can the benefits of early detection and treatment advances be demonstrated by links to declines in breast cancer mortality? And to what extent can these benefits be measured separately?

In several countries, breast cancer mortality rates have been falling steadily during the past decade. The U.S. . . . [Full Text of this Article]

Weak Science

Slippery Slope

Unknown Risks


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Am Board Fam MedHome page
B. B. Green and S. H. Taplin
Breast Cancer Screening Controversies
J Am Board Fam Med, May 1, 2003; 16(3): 233 - 241.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
L. D. Andersen, P. Remington, A. Trentham-Dietz, and M. Reeves
Assessing a Decade of Progress in Cancer Control
Oncologist, June 1, 2002; 7(3): 200 - 204.
[Abstract] [Full Text] [PDF]